NYU Langone Health exits diabetes vaccine trial

Researchers from New York City-based NYU Langone Health departed from a trial investigating a tuberculosis vaccine's potential as a pediatric Type 1 diabetes vaccine, The New York Times reported Jan. 20. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive